首页|期刊导航|眼科新进展|鼠尾草酸对青光眼大鼠视网膜的保护作用及其机制

鼠尾草酸对青光眼大鼠视网膜的保护作用及其机制OA

The protective effect of carnosic acid on the retina of glaucomatous rats and its underlying mechanism

中文摘要英文摘要

目的 探讨鼠尾草酸(CA)对青光眼大鼠视网膜的保护作用机制.方法 取90只健康雄性SPF级SD大鼠按随机数字表法分为6组,每组15只:对照组(Control组)、模型组(Model组)、鼠尾草酸低剂量组(CA-L组)、鼠尾草酸高剂量组(CA-H组)、鼠尾草酸高剂量联合受体相互作用蛋白激酶1重组蛋白(rRIP1)组(CA-H+rRIP1组)及RIP1抑制剂Nec-1组(Nec-1组).除Control组外,其余各组大鼠均以右眼为实验眼建立青光眼模型.造模成功后,各组按以下方案给药,每天1次,持续3周:CA-L组大鼠腹腔注射50 mg·kg-1 CA;CA-H 组腹腔注射 100 mg·kg-1 CA;CA-H+rRIP1 组腹腔注射 100 mg·kg-1 CA,并尾静脉注射 8 μg·kg-1 rRIP1;Nec-1 组腹腔注射 0.6 mg·kg-1 Nec-1;Control 组与 Model 组大鼠以相同给药方式给予等体积生理盐水.于干预结束后,使用GT600非接触式眼压计测量各组大鼠右眼(实验眼)眼压;采用HE染色进行组织学分析;TUNEL法检测视网膜神经节细胞(RGC)凋亡情况;免疫荧光染色检测IBA1阳性细胞率;ELISA检测各组大鼠视网膜肿瘤坏死因子α、白细胞介素-18及白细胞介素-1β含量;采用硫代巴比妥酸检测视网膜组织丙二醛(MDA)含量,羟胺法检测超氧化物歧化酶(SOD)活性,酶偶联法检测谷胱甘肽过氧化物酶(GSH-PX)活性.Western blot法检测视网膜凋亡相关蛋白表达水平.结果 与Model组相比,CA干预可显著降低青光眼大鼠的眼压,减轻视网膜组织病理损伤,增加视网膜厚度及RGC数量,并降低RGC凋亡率.同时,CA能上调小胶质细胞活化标志物IBA1的表达,降低视网膜中肿瘤坏死因子α、白细胞介素-1β和白细胞介素-18等炎症因子水平,减少氧化产物丙二醛含量,并提升抗氧化酶SOD与GSH-PX的活性.在分子层面,CA可下调促凋亡蛋白cleaved caspase-3及坏死性凋亡通路关键蛋白RIP1、RIP3和磷酸化混合系列蛋白激酶样结构域(p-MLKL)/MLKL的表达,同时上调脑源性神经营养因子的表达.而外源性补充rRIP1可部分逆转CA的上述保护作用.结论 CA可能是通过抑制RIP1/RIP3/MLKL通路来降低青光眼大鼠视网膜炎症反应、氧化应激和RGC凋亡,从而减轻视网膜损伤.

Objective To explore the protective mechanism of carnosic acid(CA)on the retina of glaucomatous rats.Methods Ninety healthy male SPF-grade SD rats were randomly divided into 6 groups according to a random num-ber table,with 15 rats in each group:control group,model group,low-dose CA group(CA-L group),high-dose CA group(CA-H group),high-dose CA combined with recombinant receptor-interacting protein kinase 1(rRIP1)group(CA-H+rRIP1 group),and RIP 1 inhibitor Nec-1 group(Nec-1 group).Except for the control group,rats in all other groups were sub-jected to glaucoma model establishment using the right eye as the experimental eye.After successful model establishment,each group received the following treatment regimens once daily for three weeks:rats in the CA-L group received an intrap-eritoneal injection of 50 mg·kg-1 CA;rats in the CA-H group received an intraperitoneal injection of 100 mg·kg-1 CA;rats in the CA-H+rRIP1 group received an intraperitoneal injection of 100 mg·kg-1 CA along with a tail vein injection of 8 µg·kg-1 rRIP1;rats in the Nec-1 group received an intraperitoneal injection of 0.6 mg·kg-1 Nec-1;rats in the control and mod-el groups were administered an equal volume of normal saline via the same injection method.After the intervention period,the intraocular pressure of the right eye(experimental eye)in rats from each group was measured using a GT600 non-con-tact tonometer.Histological analysis was performed using hematoxylin-eosin(HE)staining;the apoptosis of retinal ganglion cell(RGC)was detected by the TUNEL method;the proportion of IBA1-positive cells was assessed via immunofluorescence staining;and the levels of tumor necrosis factor-α,interleukin-18,and interleukin-1β in retinal tissues of rats from each group were measured by an enzyme-linked immunosorbent assay(ELISA).Thiobarbituric acid was used to measure the ma-londialdehyde(MDA)content in retinal tissues,the hydroxylamine method was employed to detect the superoxide dis-mutase(SOD)activity,and the enzyme coupling method was utilized to measure the glutathione peroxidase(GSH-PX)ac-tivity.Western blot is applied to measure the expression levels of retinal apoptosis-related proteins.Results Compared to the model group,CA intervention significantly reduced intraocular pressure in glaucomatous rats,alleviated retinal his-topathological damage,increased retinal thickness and the number of RGCs,and decreased the RGC apoptosis.In addition,CA upregulated the expression of the microglial activation marker IBA1,lowered the levels of inflammatory factors such as tumor necrosis factor-α,interleukin-1β,and interleukin-18 in the retina,reduced the content of the oxidative product MDA,and enhanced the activity of the antioxidant enzymes such as SOD and GSH-PX.At the molecular level,CA downregulated the expression of the pro-apoptotic protein cleaved caspase-3 and key necroptosis pathway-related proteins including RIP1,RIP3,and phosphorylated mixed lineage kinase domain-like protein(p-MLKL)/MLKL,while upregulating the expression of the brain-derived neurotrophic factor.However,exogenous supplementation of rRIP1 partially reversed the aforementioned protective effects of CA.Conclusion CA may alleviate retinal damage in glaucomatous rats by inhibiting the RIP1/RIP3/MLKL pathway and reducing retinal inflammatory response,oxidative stress,and RGC apoptosis.

何理烨;张海江

443003 湖北省宜昌市,三峡大学第一临床医学院||443003 湖北省宜昌市,宜昌市中心人民医院眼科||443003 湖北省宜昌市,三峡大学眼科与视觉科学研究所443003 湖北省宜昌市,三峡大学第一临床医学院||443003 湖北省宜昌市,宜昌市中心人民医院眼科||443003 湖北省宜昌市,三峡大学眼科与视觉科学研究所

医药卫生

RIP1/RIP3/MLKL通路鼠尾草酸青光眼视网膜神经节细胞

receptor-interacting protein kinase 1/receptor-interacting protein kinase 3/mixed lineage kinase domain-like protein pathwaycarnosic acidglaucomaretinal ganglion cell

《眼科新进展》 2026 (5)

365-370,6

湖北省自然科学基金创新发展联合基金项目(编号:2025AFD252)宜昌市科学技术局医疗卫生项目(编号:A24-2-014)

10.13389/j.cnki.rao.2026.0065

评论